Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Convatec Group PLC Board/Management Information 2019

Jun 20, 2019

4959_dirs_2019-06-20_258df60a-285d-4f0b-915f-cc044d384151.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9321C

ConvaTec Group PLC

20 June 2019

ConvaTec Director Declaration

Reading, United Kingdom (20 June 2019)

ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Margaret Ewing, Senior Independent Non-Executive Director of the Company, has been appointed as an Independent Non-Executive Director of International Consolidated Airlines Group, S.A, with effect from today.

This announcement is made in accordance with Listing Rule 9.6.14R.

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec                +44 (0)7770 842 226

Alastair Elwen, Finsbury                                                               +44 (0)207 251 3801

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                           +44 (0)7500 141 435

Mark Reynolds, Director Investor Relations, ConvaTec                +44 (0)7551 036 625

[email protected]

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RDNPGUWGQUPBGWU